|
|
||||||||
Ann Thorac Surg 1997;64:1330
© 1997 The Society of Thoracic Surgeons
Section of Cardiology, Rush-Presbyterian-St. Luke's Medical Center, 1653 W Congress Parkway, Chicago, IL 60612
| The first 20% of the full text of this article appears below. |
See also page 1325.
Cardiac allograft vasculopathy (CAV) is the leading cause of death in transplant recipients who survive more than 1 year, and is also a major cause of long-term morbidity. Cardiac allograft vasculopathy is typically concentric and diffuse, and thus continues to present a substantial diagnostic and therapeutic challenge. Concentric CAV can be inapparent by angiography even in the presence of substantial disease; intravascular ultrasound is much more sensitive. The diffuse coronary involvement limits the utility
Related Article
Ann. Thorac. Surg. 1997 64: 1325-1330.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |